Journal of the Medical Association of Thailand. Vol.96, No.6 (2013), 756-760
Suggested Citation
Arpakorn Kositwattanarerk, Wirote Changmuang, Jatupol Sangsuriyan, Kittiphong Thongklam, Chanika Sritara, Chirawat Utamakul, Wichana Chamroonrat, Kanungnij Thamnirat, Yoch Anongpornyochkul, Suporn Chancharunee <sup>131</sup>I-rituximab treatment in patient with relapsed non-Hodgkin's lymphoma: The first case report in Thailand. Journal of the Medical Association of Thailand. Vol.96, No.6 (2013), 756-760. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/32298
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
<sup>131</sup>I-rituximab treatment in patient with relapsed non-Hodgkin's lymphoma: The first case report in Thailand
Radioimmunotherapy (RIT) with131I-rituximab is a safe and effective treatment in patients with relapsed, refractory follicular lymphoma. The authors demonstrated the first case of131I-rituximab treatment in the patient with relapsed non-Hodgkin's lymphoma (NHL) in Thailand. There was no immediate complication after treatment. Impressive treatment response occurred.